Literature DB >> 9736740

Transgenic mice for interleukin 3 develop motor neuron degeneration associated with autoimmune reaction against spinal cord motor neurons.

C Chavany1, C Vicario-Abejón, G Miller, M Jendoubi.   

Abstract

Interleukin 3 (IL-3) stimulates the proliferation and differentiation of various haematopoietic progenitor cells. Recently, IL-3 and other cytokines were reported to exert a neurotrophic activity and to be associated with neurological disorders, suggesting their complex role in the central nervous system. We now show that overexpression of IL-3 in transgenic mice causes a motor neuron disease with several features of amyotrophic lateral sclerosis and progressive muscular atrophy. These animals exhibit hind limb paralysis at 7 months of age, associated with dendritic and axonal degeneration, loss of motor neurons in the spinal cord, and autoimmune reaction against these cells. We examined the effect of IL-3 on embryonic motor neurons survival in mixed spinal cord cultures. Our results suggest that motor neuronal degeneration is not directly triggered by the high level of expression of IL-3.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9736740      PMCID: PMC21646          DOI: 10.1073/pnas.95.19.11354

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

Review 1.  Molecular approaches to amyotrophic lateral sclerosis.

Authors:  R G Smith; S H Appel
Journal:  Annu Rev Med       Date:  1995       Impact factor: 13.739

2.  Cloning of rat interleukin-3 receptor beta-subunit from cultured microglia and its mRNA expression in vivo.

Authors:  K Appel; M Buttini; A Sauter; P J Gebicke-Haerter
Journal:  J Neurosci       Date:  1995-08       Impact factor: 6.167

3.  Expression of interleukin-3 and tumor necrosis factor-beta mRNAs in cultured microglia.

Authors:  K Appel; P Honegger; P J Gebicke-Haerter
Journal:  J Neuroimmunol       Date:  1995-07       Impact factor: 3.478

Review 4.  Present and future clinical relevance of interleukin 3.

Authors:  A Gianella-Borradori
Journal:  Stem Cells       Date:  1994       Impact factor: 6.277

5.  Production of interleukin-3 by murine central nervous system neurons.

Authors:  Y Konishi; M Kamegai; K Takahashi; T Kunishita; T Tabira
Journal:  Neurosci Lett       Date:  1994-12-05       Impact factor: 3.046

Review 6.  Cytokines in neurodegeneration and repair.

Authors:  N J Rothwell; P J Strijbos
Journal:  Int J Dev Neurosci       Date:  1995 Jun-Jul       Impact factor: 2.457

7.  Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis.

Authors:  M E Ripps; G W Huntley; P R Hof; J H Morrison; J W Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

8.  Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: selective effects on specific interleukins and interleukin receptors.

Authors:  D M Araujo; P A Lapchak
Journal:  Neuroscience       Date:  1994-08       Impact factor: 3.590

9.  Post-ischemic changes of [3H]glycine binding in the gerbil brain after cerebral ischemia.

Authors:  T Araki; H Kato; T Fujiwara; K Kogure; Y Itoyama
Journal:  Eur J Pharmacol       Date:  1995-05-15       Impact factor: 4.432

10.  Demonstration of interleukin-3 receptor-associated antigen in the central nervous system.

Authors:  Y Konishi; D H Chui; T Kunishita; T Yamamura; Y Higashi; T Tabira
Journal:  J Neurosci Res       Date:  1995-08-01       Impact factor: 4.164

View more
  14 in total

1.  Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration.

Authors:  Y H Gong; A S Parsadanian; A Andreeva; W D Snider; J L Elliott
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

Review 2.  Inflammation in ALS and SMA: sorting out the good from the evil.

Authors:  Dimitra Papadimitriou; Virginia Le Verche; Arnaud Jacquier; Burcin Ikiz; Serge Przedborski; Diane B Re
Journal:  Neurobiol Dis       Date:  2009-10-13       Impact factor: 5.996

3.  Interaction between interleukin 3 and dystrobrevin-binding protein 1 in schizophrenia.

Authors:  Todd L Edwards; Xu Wang; Qi Chen; Brandon Wormly; Brien Riley; F Anthony O'Neill; Dermot Walsh; Marylyn D Ritchie; Kenneth S Kendler; Xiangning Chen
Journal:  Schizophr Res       Date:  2008-09-18       Impact factor: 4.939

4.  IL-3 promotes the development of experimental autoimmune encephalitis.

Authors:  Kerstin Renner; Sonja Hellerbrand; Fabian Hermann; Christine Riedhammer; Yvonne Talke; Gabriela Schiechl; Manuel Rodriguez Gomez; Simone Kutzi; Dagmar Halbritter; Nicole Goebel; Hilke Brühl; Robert Weissert; Matthias Mack
Journal:  JCI Insight       Date:  2016-10-06

5.  CNS inflammation and neurodegeneration.

Authors:  Tanuja Chitnis; Howard L Weiner
Journal:  J Clin Invest       Date:  2017-09-05       Impact factor: 14.808

Review 6.  Transgenic mouse models of multiple sclerosis.

Authors:  Tanja Scheikl; Béatrice Pignolet; Lennart T Mars; Roland S Liblau
Journal:  Cell Mol Life Sci       Date:  2010-08-17       Impact factor: 9.261

7.  A xenograft model of macrophage activation syndrome amenable to anti-CD33 and anti-IL-6R treatment.

Authors:  Mark Wunderlich; Courtney Stockman; Mahima Devarajan; Navin Ravishankar; Christina Sexton; Ashish R Kumar; Benjamin Mizukawa; James C Mulloy
Journal:  JCI Insight       Date:  2016-09-22

8.  Association study of CSF2RB with schizophrenia in Irish family and case - control samples.

Authors:  Q Chen; X Wang; F A O'Neill; D Walsh; A Fanous; K S Kendler; X Chen
Journal:  Mol Psychiatry       Date:  2007-07-31       Impact factor: 15.992

9.  Assessment of faithful interleukin-3 production by novel bicistronic interleukin-3 reporter mice.

Authors:  Tracy L Deem; James B Collins; Madison H DeVost; Chandler O Parker; Shelby C Saroka; Ryan J Zoldork; Fernando Gutierrez; Jenny M Russell; Chris S Lantz
Journal:  Immunol Lett       Date:  2020-02-18       Impact factor: 3.685

10.  Anti-CTLA-4 synergizes with dendritic cell-targeted vaccine to promote IL-3-dependent CD4+ effector T cell infiltration into murine pancreatic tumors.

Authors:  Neeha Zaidi; Sergio A Quezada; Janelle M Y Kuroiwa; Li Zhang; Elizabeth M Jaffee; Ralph M Steinman; Bei Wang
Journal:  Ann N Y Acad Sci       Date:  2019-04-04       Impact factor: 6.499

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.